Therefore, our study demonstrates that PRMT6 could contribute to the proliferation and invasiveness of glioblastoma cells in vivo, which is the main reason why PRMT6 is identified as an oncogene in glioma. This evidence concerns the gene PRMT6 and central nervous system cancer.